Literature DB >> 30814930

Comparative Phosphoproteomic Profiling of Type III Adenylyl Cyclase Knockout and Control, Male, and Female Mice.

Yuxin Zhou1, Liyan Qiu1, Ashley Sterpka1, Haiying Wang2, Feixia Chu1, Xuanmao Chen1.   

Abstract

Type III adenylyl cyclase (AC3, ADCY3) is predominantly enriched in neuronal primary cilia throughout the central nervous system (CNS). Genome-wide association studies in humans have associated ADCY3 with major depressive disorder and autistic spectrum disorder, both of which exhibit sexual dimorphism. To date, it is unclear how AC3 affects protein phosphorylation and signal networks in central neurons, and what causes the sexual dimorphism of autism. We employed a mass spectrometry (MS)-based phosphoproteomic approach to quantitatively profile differences in phosphorylation between inducible AC3 knockout (KO) and wild type (WT), male and female mice. In total, we identified 4,655 phosphopeptides from 1,756 proteins, among which 565 phosphopeptides from 322 proteins were repetitively detected in all samples. Over 46% phosphopeptides were identified in at least three out of eight biological replicas. Comparison of AC3 KO and WT datasets revealed that phosphopeptides with motifs matching proline-directed kinases' recognition sites had a lower abundance in the KO dataset than in WTs. We detected 14 phosphopeptides restricted to WT dataset (i.e., Rabl6, Spast and Ppp1r14a) and 35 exclusively in KOs (i.e., Sptan1, Arhgap20, Arhgap44, and Pde1b). Moreover, 95 phosphopeptides (out of 90 proteins) were identified only in female dataset and 26 only in males. Label-free MS spectrum quantification using Skyline further identified phosphopeptides that had higher abundance in each sample group. In total, 204 proteins had sex-biased phosphorylation and 167 of them had increased expression in females relative to males. Interestingly, among the 204 gender-biased phosphoproteins, 31% were found to be associated with autism, including Dlg1, Dlgap2, Syn1, Syngap1, Ctnna1, Ctnnd1, Ctnnd2, Pkp4, and Arvcf. Therefore, this study also provides the first phosphoproteomics evidence suggesting that gender-biased post-translational phosphorylation may be implicated in the sexual dimorphism of autism.

Entities:  

Keywords:  Type III adenylyl cyclase (AC3); autistic spectrum disorder (ASD); delta catenin; gender-biased phosphorylation; major depressive disorder (MDD); phosphoproteomics; primary cilia; sexual dimorphism of autism

Year:  2019        PMID: 30814930      PMCID: PMC6381875          DOI: 10.3389/fncel.2019.00034

Source DB:  PubMed          Journal:  Front Cell Neurosci        ISSN: 1662-5102            Impact factor:   5.505


  75 in total

Review 1.  Intraflagellar transport.

Authors:  Joel L Rosenbaum; George B Witman
Journal:  Nat Rev Mol Cell Biol       Date:  2002-11       Impact factor: 94.444

2.  STRING: a database of predicted functional associations between proteins.

Authors:  Christian von Mering; Martijn Huynen; Daniel Jaeggi; Steffen Schmidt; Peer Bork; Berend Snel
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

3.  Cerebellar long-term synaptic depression requires PKC-mediated activation of CPI-17, a myosin/moesin phosphatase inhibitor.

Authors:  Masumi Eto; Roland Bock; David L Brautigan; David J Linden
Journal:  Neuron       Date:  2002-12-19       Impact factor: 17.173

4.  Comprehensive analysis of a multidimensional liquid chromatography mass spectrometry dataset acquired on a quadrupole selecting, quadrupole collision cell, time-of-flight mass spectrometer: II. New developments in Protein Prospector allow for reliable and comprehensive automatic analysis of large datasets.

Authors:  Robert J Chalkley; Peter R Baker; Lan Huang; Kirk C Hansen; Nadia P Allen; Michael Rexach; Alma L Burlingame
Journal:  Mol Cell Proteomics       Date:  2005-06-03       Impact factor: 5.911

5.  Disruption of the type III adenylyl cyclase gene leads to peripheral and behavioral anosmia in transgenic mice.

Authors:  S T Wong; K Trinh; B Hacker; G C Chan; G Lowe; A Gaggar; Z Xia; G H Gold; D R Storm
Journal:  Neuron       Date:  2000-09       Impact factor: 17.173

Review 6.  Signaling from cAMP/PKA to MAPK and synaptic plasticity.

Authors:  Robert Waltereit; Michael Weller
Journal:  Mol Neurobiol       Date:  2003-02       Impact factor: 5.590

7.  Functional genomics of the cilium, a sensory organelle.

Authors:  Oliver E Blacque; Elliot A Perens; Keith A Boroevich; Peter N Inglis; Chunmei Li; Adam Warner; Jaswinder Khattra; Rob A Holt; Guangshuo Ou; Allan K Mah; Sheldon J McKay; Peter Huang; Peter Swoboda; Steve J M Jones; Marco A Marra; David L Baillie; Donald G Moerman; Shai Shaham; Michel R Leroux
Journal:  Curr Biol       Date:  2005-05-24       Impact factor: 10.834

8.  Negative feedback regulation ensures the one receptor-one olfactory neuron rule in mouse.

Authors:  Shou Serizawa; Kazunari Miyamichi; Hiroko Nakatani; Misao Suzuki; Michiko Saito; Yoshihiro Yoshihara; Hitoshi Sakano
Journal:  Science       Date:  2003-10-30       Impact factor: 47.728

9.  Comparative genomics identifies a flagellar and basal body proteome that includes the BBS5 human disease gene.

Authors:  Jin Billy Li; Jantje M Gerdes; Courtney J Haycraft; Yanli Fan; Tanya M Teslovich; Helen May-Simera; Haitao Li; Oliver E Blacque; Linya Li; Carmen C Leitch; Richard Allan Lewis; Jane S Green; Patrick S Parfrey; Michel R Leroux; William S Davidson; Philip L Beales; Lisa M Guay-Woodford; Bradley K Yoder; Gary D Stormo; Nicholas Katsanis; Susan K Dutcher
Journal:  Cell       Date:  2004-05-14       Impact factor: 41.582

10.  Depletion of MAP2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals.

Authors:  E B Mukaetova-Ladinska; H Arnold; E Jaros; R Perry; E Perry
Journal:  Neuropathol Appl Neurobiol       Date:  2004-12       Impact factor: 8.090

View more
  1 in total

Review 1.  Expression and functions of adenylyl cyclases in the CNS.

Authors:  Karan Devasani; Yao Yao
Journal:  Fluids Barriers CNS       Date:  2022-03-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.